{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:46:24Z","timestamp":1780512384575,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10067-017-3912-2","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T23:09:53Z","timestamp":1510528193000},"page":"1421-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sj\u00f6gren\u2019s syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review"],"prefix":"10.1007","volume":"37","author":[{"given":"Xiaohan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"issue":"2","key":"3912_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s10165-004-0287-4","volume":"14","author":"H Abe","year":"2004","unstructured":"Abe H, Tsuboi N, Yukawa S, Tsuji S, Hayashi H, Yukawa N, Takanashi H, Tahara K, Tonozuka N, Hayashi T (2004) Thrombotic thrombocytopenic purpura complicating Sjogren\u2019s syndrome with crescentic glomerulonephritis and membranous nephritis. Mod Rheumatol 14(2):174\u2013178. \nhttps:\/\/doi.org\/10.1007\/s10165-004-0287-4","journal-title":"Mod Rheumatol"},{"key":"3912_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.12659\/AJCR.898955","volume":"17","author":"M Abu-Hishmeh","year":"2016","unstructured":"Abu-Hishmeh M, Sattar A, Zarlasht F, Ramadan M, Abdel-Rahman A, Hinson S, Hwang C (2016) Systemic lupus erythematosus presenting as refractory thrombotic thrombocytopenic purpura: a diagnostic and management challenge. A case report and concise review of the literature. Am J Case Rep 17:782\u2013787. \n10.12659\/AJCR.898955","journal-title":"Am J Case Rep"},{"issue":"8","key":"3912_CR3","first-page":"844","volume":"86","author":"DS Allan","year":"2001","unstructured":"Allan DS, Kovacs MJ, Clark WF (2001) Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy. Haematologica 86(8):844\u2013850","journal-title":"Haematologica"},{"issue":"4 Suppl 98","key":"3912_CR4","first-page":"58","volume":"34","author":"F Barone","year":"2016","unstructured":"Barone F, Colafrancesco S (2016) Sjogren\u2019s syndrome: from pathogenesis to novel therapeutic targets. Clin Exp Rheumatol 34(4 Suppl 98):58\u201362","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3912_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/rheumatology\/keu320","volume":"54","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni E, Alunno A, Bistoni O, Caterbi S, Luccioli F, Santoboni G, Mirabelli G, Cannarile F, Gerli R (2015) Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjogren\u2019s syndrome: new markers of chronic endothelial damage? Rheumatology (Oxford) 54(3):536\u2013544. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keu320","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3912_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1111\/j.1537-2995.2012.03578.x","volume":"52","author":"F Beloncle","year":"2012","unstructured":"Beloncle F, Buffet M, Coindre JP, Munoz-Bongrand N, Malot S, Pene F, Mira JP, Galicier L, Guidet B, Baudel JL, Subra JF, Tanguy-Schmidt A, Pourrat J, Azoulay E, Veyradier A, Coppo P (2012) Splenectomy and\/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Transfusion 52(11):2436\u20132444. \nhttps:\/\/doi.org\/10.1111\/j.1537-2995.2012.03578.x","journal-title":"Transfusion"},{"issue":"1","key":"3912_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-015-0037-7","volume":"6","author":"JE Brandt","year":"2015","unstructured":"Brandt JE, Priori R, Valesini G, Fairweather D (2015) Sex differences in Sjogren\u2019s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ 6(1):19. \nhttps:\/\/doi.org\/10.1186\/s13293-015-0037-7","journal-title":"Biol Sex Differ"},{"issue":"5","key":"3912_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/bor.0000000000000096","volume":"26","author":"P Brito-Zeron","year":"2014","unstructured":"Brito-Zeron P, Ramos-Casals M (2014) Advances in the understanding and treatment of systemic complications in Sjogren\u2019s syndrome. Curr Opin Rheumatol 26(5):520\u2013527. \nhttps:\/\/doi.org\/10.1097\/bor.0000000000000096","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"3912_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1445-5994.1998.tb02974.x","volume":"28","author":"GN Campbell","year":"1998","unstructured":"Campbell GN, Gallo JH (1998) Relapsing thrombotic thrombocytopenic purpura (TTP) in Sjogren\u2019s syndrome. Aust NZ J Med 28(2):214. \nhttps:\/\/doi.org\/10.1111\/j.1445-5994.1998.tb02974.x","journal-title":"Aust NZ J Med"},{"issue":"3","key":"3912_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1538-7836.2006.02361.x","volume":"5","author":"AK Chauhan","year":"2007","unstructured":"Chauhan AK, Goerge T, Schneider SW, Wagner DD (2007) Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin. J Thromb Haemost 5(3):583\u2013589. \nhttps:\/\/doi.org\/10.1111\/j.1538-7836.2006.02361.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3912_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.transci.2016.12.019","volume":"56","author":"P Coppo","year":"2017","unstructured":"Coppo P (2017) Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms. Transfus Apher Sci 56(1):52\u201356. \nhttps:\/\/doi.org\/10.1016\/j.transci.2016.12.019","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"3912_CR12","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/j.lpm.2011.10.024","volume":"41","author":"P Coppo","year":"2012","unstructured":"Coppo P, Veyradier A (2012) Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Presse Med 41(3):e163\u2013e176. \nhttps:\/\/doi.org\/10.1016\/j.lpm.2011.10.024","journal-title":"Presse Med"},{"issue":"Suppl 1","key":"3912_CR13","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1002\/ajh.23126","volume":"87","author":"JN George","year":"2012","unstructured":"George JN (2012) Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol 87(Suppl 1):S88\u2013S91. \nhttps:\/\/doi.org\/10.1002\/ajh.23126","journal-title":"Am J Hematol"},{"issue":"1","key":"3912_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21164\/pomjlifesci.48","volume":"61","author":"R Guzicka-Kazimierczak","year":"2015","unstructured":"Guzicka-Kazimierczak R, Kazimierczak A, Clark J (2015) Promising results from cyclophosphamide based immunosuppression therapy of thrombotic thrombocytopenic purpura. Pomeranian J Life Sci 61(1):34\u201340","journal-title":"Pomeranian J Life Sci"},{"issue":"4","key":"3912_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1445-5994.1997.tb02204.x","volume":"27","author":"MS Hertzberg","year":"1997","unstructured":"Hertzberg MS, Koutts J (1997) Oral cyclophosphamide for refractory or relapsing thrombotic thrombocytopenic purpura (TTP). Aust NZ J Med 27(4):439. \nhttps:\/\/doi.org\/10.1111\/j.1445-5994.1997.tb02204.x","journal-title":"Aust NZ J Med"},{"issue":"17","key":"3912_CR16","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1001\/jama.2013.278448","volume":"310","author":"R Jonsson","year":"2013","unstructured":"Jonsson R, Theander E, Sjostrom B, Brokstad K, Henriksson G (2013) Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA 310(17):1854\u20131855. \nhttps:\/\/doi.org\/10.1001\/jama.2013.278448","journal-title":"JAMA"},{"issue":"04","key":"3912_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-0034-1376883","volume":"40","author":"P Knobl","year":"2014","unstructured":"Knobl P (2014) Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults. Semin Thromb Hemost 40(04):493\u2013502. \nhttps:\/\/doi.org\/10.1055\/s-0034-1376883","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3912_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00296-010-1569-0","volume":"33","author":"T Koga","year":"2013","unstructured":"Koga T, Yamasaki S, Nakamura H, Kawakami A, Furusu A, Taguchi T, Eguchi K (2013) Renal thrombotic microangiopathies\/thrombotic thrombocytopenic purpura in a patient with primary Sjogren\u2019s syndrome complicated with IgM monoclonal gammopathy of undetermined significance. Rheumatol Int 33(1):227\u2013230. \nhttps:\/\/doi.org\/10.1007\/s00296-010-1569-0","journal-title":"Rheumatol Int"},{"issue":"10","key":"3912_CR19","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/blood-2014-10-559211","volume":"125","author":"W Lim","year":"2015","unstructured":"Lim W, Vesely SK, George JN (2015) The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood 125(10):1526\u20131531. \nhttps:\/\/doi.org\/10.1182\/blood-2014-10-559211","journal-title":"Blood"},{"issue":"5","key":"3912_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.5114\/aoms.2012.30788","volume":"8","author":"TY Lin","year":"2012","unstructured":"Lin TY, Chang CC, Chang CC, Yuan JY, Chen HH (2012) Cyclophosphamide-rescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjogren\u2019s syndrome. Arch Med Sci 8(5):934\u2013938. \nhttps:\/\/doi.org\/10.5114\/aoms.2012.30788","journal-title":"Arch Med Sci"},{"issue":"5","key":"3912_CR21","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/s2352-3026(16)30018-7","volume":"3","author":"E Mariotte","year":"2016","unstructured":"Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provot F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A (2016) Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol 3(5):e237\u2013e245. \nhttps:\/\/doi.org\/10.1016\/s2352-3026(16)30018-7","journal-title":"Lancet Haematol"},{"issue":"1","key":"3912_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.blre.2005.02.001","volume":"20","author":"RJ Murrin","year":"2006","unstructured":"Murrin RJ, Murray JA (2006) Thrombotic thrombocytopenic purpura: aetiology, pathophysiology and treatment. Blood Rev 20(1):51\u201360. \nhttps:\/\/doi.org\/10.1016\/j.blre.2005.02.001","journal-title":"Blood Rev"},{"issue":"2","key":"3912_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ajcp\/94.2.217","volume":"94","author":"M Noda","year":"1990","unstructured":"Noda M, Kitagawa M, Tomoda F, Iida H (1990) Thrombotic thrombocytopenic purpura as a complicating factor in a case of polymyositis and Sjogren\u2019s syndrome. Am J Clin Pathol 94(2):217\u2013221. \nhttps:\/\/doi.org\/10.1093\/ajcp\/94.2.217","journal-title":"Am J Clin Pathol"},{"issue":"17","key":"3912_CR24","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1182\/blood-2016-06-724161","volume":"128","author":"EE Page","year":"2016","unstructured":"Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN (2016) Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood 128(17):2175\u20132178. \nhttps:\/\/doi.org\/10.1182\/blood-2016-06-724161","journal-title":"Blood"},{"issue":"24","key":"3912_CR25","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1182\/blood-2016-03-70382","volume":"127","author":"EE Page","year":"2016","unstructured":"Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN (2016) Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood 127(24):3092\u20133094. \nhttps:\/\/doi.org\/10.1182\/blood-2016-03-70382","journal-title":"Blood"},{"issue":"1","key":"3912_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1196\/annals.1422.045","volume":"1108","author":"P Porola","year":"2007","unstructured":"Porola P, Laine M, Virkki L, Poduval P, Konttinen YT (2007) The influence of sex steroids on Sjogren\u2019s syndrome. Ann N Y Acad Sci 1108(1):426\u2013432. \nhttps:\/\/doi.org\/10.1196\/annals.1422.045","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"3912_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3899\/jrheum.091354","volume":"37","author":"P Porola","year":"2010","unstructured":"Porola P, Laine M, Virtanen I, Pollanen R, Przybyla BD, Konttinen YT (2010) Androgens and integrins in salivary glands in Sjogren\u2019s syndrome. J Rheumatol 37(6):1181\u20131187. \nhttps:\/\/doi.org\/10.3899\/jrheum.091354","journal-title":"J Rheumatol"},{"issue":"42","key":"3912_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000001598","volume":"94","author":"M Roriz","year":"2015","unstructured":"Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provot F, Pene F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M, Coppo P (2015) Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura. Medicine (Baltimore) 94(42):e1598. \nhttps:\/\/doi.org\/10.1097\/md.0000000000001598","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3912_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/asheducation-2004.1.407","volume":"2004","author":"JE Sadler","year":"2004","unstructured":"Sadler JE, Moake JL, Miyata T, George JN (2004) Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004(1):407\u2013423. \nhttps:\/\/doi.org\/10.1182\/asheducation-2004.1.407","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"3912_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874312901409010036","volume":"9","author":"P Sandhya","year":"2015","unstructured":"Sandhya P, Jeyaseelan L, Scofield RH, Danda D (2015) Clinical characteristics and outcome of primary Sjogren\u2019s syndrome: a large Asian Indian cohort. Open Rheumatol J 9(1):36\u201345. \nhttps:\/\/doi.org\/10.2174\/1874312901409010036","journal-title":"Open Rheumatol J"},{"issue":"25","key":"3912_CR31","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1182\/blood-2014-11-551580","volume":"125","author":"FA Sayani","year":"2015","unstructured":"Sayani FA, Abrams CS (2015) How I treat refractory thrombotic thrombocytopenic purpura. Blood 125(25):3860\u20133867. \nhttps:\/\/doi.org\/10.1182\/blood-2014-11-551580","journal-title":"Blood"},{"issue":"1","key":"3912_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s100670200013","volume":"21","author":"A Schattner","year":"2002","unstructured":"Schattner A, Friedman J, Klepfish A (2002) Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjogren\u2019s syndrome. Clin Rheumatol 21(1):57\u201359. \nhttps:\/\/doi.org\/10.1007\/s100670200013","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3912_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, Lammle B, Matsumoto M, Pavenski K, Sadler E, Sarode R, Wu H (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15(2):312\u2013322. \nhttps:\/\/doi.org\/10.1111\/jth.13571","journal-title":"J Thromb Haemost"},{"issue":"19","key":"3912_CR34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0025-7753(01)71965-3","volume":"116","author":"A Selva O'Callaghan","year":"2001","unstructured":"Selva O'Callaghan A, Bosch Gil JA, Solans Laque R, Segura Garcia A, Armadans Gil L, Mijares Boeckh-Behrens T, Vilardell Tarres M (2001) Primary Sjogren\u2019s syndrome: clinical and immunological characteristics of 114 patients. Med Clin (Barc) 116(19):721\u2013725","journal-title":"Med Clin (Barc)"},{"issue":"4-5","key":"3912_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.autrev.2014.01.004","volume":"13","author":"B Shenkman","year":"2014","unstructured":"Shenkman B, Einav Y (2014) Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev 13(4-5):584\u2013586. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2014.01.004","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3912_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3912_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jama.1971.03180180033007","volume":"215","author":"AD Steinberg","year":"1971","unstructured":"Steinberg AD, Green WT Jr, Talal N (1971) Thrombotic thrombocytopenic purpura complicating Sjogren\u2019s syndrome. JAMA 215(5):757\u2013761. \nhttps:\/\/doi.org\/10.1001\/jama.1971.03180180033007","journal-title":"JAMA"},{"issue":"2","key":"3912_CR38","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/MJT.0b013e3182459aa0","volume":"21","author":"A Toumeh","year":"2014","unstructured":"Toumeh A, Josh N, Narwal R, Assaly R (2014) Refractory thrombotic thrombocytopenic purpura associated with primary Sjogren syndrome treated with rituximab: a case report. Am J Ther 21(2):e56\u2013e60. \nhttps:\/\/doi.org\/10.1097\/MJT.0b013e3182459aa0","journal-title":"Am J Ther"},{"issue":"1","key":"3912_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MBC.0b013e32833335eb","volume":"21","author":"L Verbeke","year":"2010","unstructured":"Verbeke L, Delforge M, Dierickx D (2010) Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis 21(1):3\u201310. \nhttps:\/\/doi.org\/10.1097\/MBC.0b013e32833335eb","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"3912_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/trf.12762","volume":"55","author":"N Wu","year":"2015","unstructured":"Wu N, Liu J, Yang S, Kellett ET, Cataland SR, Li H, HM W (2015) Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura. Transfusion 55(1):18\u201324. \nhttps:\/\/doi.org\/10.1111\/trf.12762","journal-title":"Transfusion"},{"issue":"2","key":"3912_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10165-012-0644-7","volume":"23","author":"H Yamashita","year":"2013","unstructured":"Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A (2013) Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sjogren\u2019s syndrome: two cases and a literature review. Mod Rheumatol 23(2):365\u2013373. \nhttps:\/\/doi.org\/10.1007\/s10165-012-0644-7","journal-title":"Mod Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3912-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T10:05:30Z","timestamp":1524477930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3912-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]}}}